(0)
  +91-9310585862, 9310585859

Skin Tightening Technology

The Biological Skin Tightening

We can best demonstrate how the body tightens skin when we observe how wounds heal. Wounds are closed by two mechanisms. First tissue rebuilds within the injured area; and secondly, the skin contracts around the wound. When we use copper peptides, we can enhance the process of healing wounds and thus tighten skin.

The Natural Way to Tighten Skin

We can visualize young skin as the surface of a buoyant balloon; push it in or pull it out and it quickly returns to a smooth surface. Like a balloon, biological skin tightening arises as the skin's repair cells and the fibroblasts pull collagen strands together. The fibroblasts biochemically attach collagen strands to each other. This natural skin tightening process keeps the skin elastic and soft. The fibroblasts use an enzyme called lysyl oxidase to connect the collagen strands. The radio wavelengths safely penetrate the skin with vibrations; these vibrations target the water molecules in the area being treated, causing them to move and heat up. This heat causes the skin tissue to begin shrinking whilst stimulating the remodeling of collagen cells- the main component that gives skin its structure and fullness.

Radio Frequency technology for skin tightening

the dermis and subcutaneous layer are heated simultaneously forcing collagen fibres to contract. The contracting fibres pull and tighten the skin, creating an immediate effect. Fibroblasts' metabolism increases, producing new collagen fibres leaving a long term effect. Most of the RadioFrequency energy enters into the deeper dermal layer, causing the dermal layer of skin to thicken, decreasing wrinkle depth, leaving the skin firmer with contour lifted. The original collagen protein becomes strengthened to increase the new collagen protein as a result of the radio frequency stimulating the skin.

Supporting studies 

Facial tightening with an advanced 4-MHz monopolar radiofrequency device. Taub AF, Tucker RD, Palange A. o Advanced Dermatology, Lincolnshire, IL, USA. drtaub@skinfo.com

BACKGROUND:

Over the past 10 years, radiofrequency (RF) technology has been utilized for nonablative treatments for the treatment of rhytides and skin laxity. This manuscript reviews the scientific background of collagen synthesis in vivo and in response to RF energy as well as a clinical study of 17 patients receiving a series of facial treatments with a 4- MHz monopolar RF (Pellevé, Ellman International, Inc, Oceanside, NY). Clinical methods, results, and a review of the literature for RF aesthetic treatments of the face are presented.

METHODS:

Seventeen patients were treated in one site with 6 total treatments scheduled as follows: 1 session was performed every 15 days for 2 consecutive sessions, 1 session every month for 2 consecutive sessions, and 1 session every 2 months for 2 consecutive sessions. Both the treating physician and the patients via live viewing and comparison with baseline photographs performed assessment of results. Results are reported as averages across the 17 patients.

RESULTS:

Two weeks after the first treatment, patients noted an overall average of 25% to 30% improvement. Just before the last or sixth treatment, there was an average of 50% improvement noted by the physician, with patients ranking an average self-improvement of 48%. The treating physician rated average improvement of 46% compared with baseline, whereas the patients ranked average improvement of 30% compared with baseline at 1 year after treatment was initiated (6 months after the final treatment). Patients find this treatment to be very well tolerated, with minimal to no discomfort and no downtime or significant side effects.

CONCLUSIONS:

The Pellevé 4-MHz monopolar RF device is effective, safe, and very well tolerated for treating laxity, texture, and wrinkles of the skin without complication or discomfort. Evidence in the literature supports the scientific mechanism of action of acute collagen modification and continued neocollagenesis observed with the system. In this cohort, patients maintain approximately 50% improvement on average at 6 months and a 30% to 50% improvement 1 year after beginning the treatments, 6 months after completion.